Stay updated on Adjunctive Effects of Psilocybin & Buprenorphine Formulation Clinical Trial
Sign up to get notified when there's something new on the Adjunctive Effects of Psilocybin & Buprenorphine Formulation Clinical Trial page.

Latest updates to the Adjunctive Effects of Psilocybin & Buprenorphine Formulation Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedThe expected modernization date for the ClinicalTrials.gov data ingest has been updated from June 2025 to July 2025.SummaryDifference0.9%
- Check20 days agoChange DetectedThe page has been updated to reflect the latest version as v2.16.3, replacing the previous version v2.16.2. The estimated last update posted has been removed.SummaryDifference0.1%
- Check27 days agoChange DetectedThe webpage has updated its version from v2.16.1 to v2.16.2 and has made changes to the dates listed, removing some past dates and adding future ones.SummaryDifference0.9%
- Check35 days agoChange DetectedThe web page has been updated to reflect the upcoming modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, along with an invitation for API users to provide input. Additionally, the revision number has been updated from v2.16.0 to v2.16.1.SummaryDifference1%
- Check63 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.1%
- Check78 days agoChange DetectedThe webpage has undergone significant changes, including the removal of detailed descriptions of the clinical trial's primary and secondary aims, as well as the inclusion of new identifiers and collaborators related to the study on opioid use disorder. The revision version has also been updated.SummaryDifference36%
Stay in the know with updates to Adjunctive Effects of Psilocybin & Buprenorphine Formulation Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Adjunctive Effects of Psilocybin & Buprenorphine Formulation Clinical Trial page.